Author:
Wang Dan,Deng Xijin,Li Shanshan,Sana Si Ri Gu Leng
Funder
Beijing Afforestation Foundation
Harbin Medical University
Reference31 articles.
1. B. Ziad, H. Jessica E, C. Toni K, P. Solange, R. Brian I, W. Jeremy L, P. Corrie A, COVID-19 and Cancer: Current Challenges and Perspectives, Cancer Cell 38 (2020). doi: 10.1016/j.ccell.2020.09.018.
2. Epigenomic Reprogramming as a Driver of Malignant Glioma;Richard E;Cancer Cell,2020
3. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort;Laurence;Nat Cancer,2020
4. G. Marina Chiara, W. Jennifer G, H. Li-Ching, T. Annalisa, T. Valter, A. Francesco, B. Javier, B. Giuseppe, B. Rossana, B. Anna Cecilia, B. Emilio, B. Matteo, C. Jacques, D.T. Alessandro, C. Claudio, C. Alessio, F. Enriqueta, F. Giovanna, G. Pilar, G. Carlo, G. Raffaele, G. Vanesa, G. Francesco, G. Federica, I. Salvatore, L.V. Nicla, L. Stephen V, M. Julien, M. Edoardo, M. Olivier, M. Gabriele, M.-S. Denis, P. Giulia, P. Antonio, S. Vieri, S. Piergiorgio, S. Elisa, T. Marcello, V. Giuseppe, V. Luca, W. Yi-Long, Z. Silvia, P. Vera, D. Anne-Marie, V.M. Jan, B. Fabrice, W. Heather, P. Solange, H. Leora, COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study, Lancet Oncol 21 (2020). doi: 10.1016/s1470-2045(20)30314-4.
5. G. Vassilis G, P. Eleni, S. Ilias I, Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data, JCO Glob Oncol 6 (2020). doi: 10.1200/go.20.00225.